Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

EGFR

  • You have access
    Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
    MD MOHIUDDIN and KAZUO KASAHARA
    Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
  • Open Access
    Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma
    YOON AH CHO, SANGJOON CHOI, SUJIN PARK, CHEOL-KEUN PARK and SANG YUN HA
    Cancer Genomics & Proteomics November 2020, 17 (6) 747-755; DOI: https://doi.org/10.21873/cgp.20229
  • Open Access
    Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
    MATHIEU CHEVALLIER, PETROS TSANTOULIS, ALFREDO ADDEO and ALEX FRIEDLAENDER
    Cancer Genomics & Proteomics September 2020, 17 (5) 597-603; DOI: https://doi.org/10.21873/cgp.20216
  • Open Access
    Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment
    HELENA LINARDOU, VASSILIKI KOTOULA, GEORGE KOUVATSEAS, GIANNIS MOUNTZIOS, VASILIOS KARAVASILIS, EPAMINONDAS SAMANTAS, ANNA KALOGERA-FOUNTZILA, DESPINA TELEVANTOU, KYRIAKI PAPADOPOULOU, XANTHIPI MAVROPOULOU, EMILY DASKALAKI, THOMAS ZARAMBOUKAS, IOANNIS EFSTRATIOU, SOFIA LAMPAKI, GRIGORIOS RALLIS, ELENI RES, KONSTANTINOS N. SYRIGOS, PARIS A. KOSMIDIS, DIMITRIOS PECTASIDES and GEORGE FOUNTZILAS
    Cancer Genomics & Proteomics November 2019, 16 (6) 531-541; DOI: https://doi.org/10.21873/cgp.20155
  • Open Access
    Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study
    GEORGIA KARPATHIOU, MARIE-LAURIE STACHOWITZ, JEAN MARC DUMOLLARD, MARIE GAVID, MARIOS FROUDARAKIS, JEAN MICHEL PRADES and MICHEL PEOC'H
    Cancer Genomics & Proteomics May 2019, 16 (3) 155-161; DOI: https://doi.org/10.21873/cgp.20121
  • Open Access
    EGFR L861Q Mutation in a Metastatic Solid-pseudopapillary Neoplasm of the Pancreas
    KEVIN G. NEILL, JAMES SALLER, SAMEER AL DIFFALHA, BARBARA A. CENTENO, MOKENGE P. MALAFA and DOMENICO COPPOLA
    Cancer Genomics & Proteomics May 2018, 15 (3) 201-205;
  • Open Access
    Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers
    SOFIA LEVVA, VASSILIKI KOTOULA, IOANNIS KOSTOPOULOS, KYRIAKI MANOUSOU, CHRISTOS PAPADIMITRIOU, KYRIAKI PAPADOPOULOU, SOTIRIS LAKIS, KYRIAKOS KOUKOULIAS, VASILIOS KARAVASILIS, GEORGE PENTHEROUDAKIS, EUFEMIA BALASSI, FLORA ZAGOURI, IOANNIS G. KAKLAMANOS, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GERASIMOS ARAVANTINOS, PAVLOS PAPAKOSTAS, DIMITRIOS BAFALOUKOS, GRIGORIOS RALLIS, HELEN GOGAS and GEORGE FOUNTZILAS
    Cancer Genomics & Proteomics May 2017, 14 (3) 181-195;
  • Open Access
    Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas
    ANCA MARIA CIMPEAN, RALUCA AMALIA BALICA, IOAN CAIUS DOROS, NICOLAE CONSTANTIN BALICA, PUSA NELA GAJE, RAMONA AMINA POPOVICI and MARIUS RAICA
    Cancer Genomics & Proteomics January 2016, 13 (1) 75-81;
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire